Free shipping on all orders over $ 500

 About 1 result found for searched term "2283348-97-8" (0.121 seconds)

Cat.No.  Name Target
M25068 Lirentelimab Apoptosis
AK002; Anti-Siglec-8 Reference Antibody
Lirentelimab (AK002) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated mast cell activation. Lirentelimab can be used for the research of eosinophilic gastritis and duodenitis.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.